Clinical Trials Browser

Phase 3 × Lymphoma, Mantle-Cell × Maintenance × Clear all

NCT02858258 2017-12-19

ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma

Phase 3 Unknown

Lymphoma, Mantle-Cell